GLUC
Glucose Health, Inc.
Key Financials
Net Income
$-410443
↓ 54.3%
Gross Profit
$19167
↑ 4728.0%
Operating Income
$-86647
↑ 44.5%
Shareholders' Equity
$-495447.00
↓ 27.8%
Total Assets
$33145.00
↑ 115.1%
Cash & Equivalents
$20542.00
↑ 899.6%
Total Liabilities
$528592.00
↑ 31.1%
Operating Cash Flow
$-39263.00
↑ 66.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| D | 2/4/2026 | View on SEC |
| D | 12/5/2025 | View on SEC |
| D/A | 1/19/2024 | View on SEC |
| D | 12/7/2023 | View on SEC |
| RW | 6/28/2023 | View on SEC |
| S-1/A | 1/9/2023 | View on SEC |
| S-1/A | 9/6/2022 | View on SEC |
| S-1/A | 8/5/2022 | View on SEC |
| S-1 | 6/1/2022 | View on SEC |
| D | 3/9/2021 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | GLUC |
| Company Name | Glucose Health, Inc. |
| CIK | 1420108 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 479-802-3827 |